Paulius Ojeras
YOU?
Author Swipe
View article: S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES
S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES Open
Background: Autologous CAR T-cell therapies have altered the treatment landscape for many patients with advanced B-cell malignancies, however custom manufacturing precludes prompt treatment and can result in manufacturing failure. Further,…
View article: First in human data of NKX019, an allogeneic CAR NK for the treatment of relapsed/refractory (R/R) B‐cell malignancies
First in human data of NKX019, an allogeneic CAR NK for the treatment of relapsed/refractory (R/R) B‐cell malignancies Open
Background: Autologous CAR T-cell therapies have altered the treatment landscape for many patients (pts) with advanced B-cell malignancies, however custom manufacturing precludes prompt treatment and can result in manufacturing failure. T-…